Investing Profile

Brett Zbar

VCInvestor
Managing Director and Global Head of Life Sciences at General Atlantic
generalatlantic.comNew York, New York
Photo of Brett Zbar, Managing Director at General Atlantic

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Mckinsey & Company Network
726 CONNECTIONS
Yale University Network
410 CONNECTIONS
McKinsey & Company Network
276 CONNECTIONS
General Atlantic Network
102 CONNECTIONS
Harvard Medical School Network
64 CONNECTIONS
cb
General Atlantic Managing Director
$100K - $5.0M
$1.5M
15
$78B
CompanyStageDateRound SizeTotal Raised
Expedition Therapeutics
Series BAug 2026$120M
$280M
Co-investors: Jonathan Leff (Sofinnova Investments)
Allonnia
Series ADec 2025$20M
$20M
Verdiva Bio
Series AJan 2025$410M
$410M
Co-investors: Wouter Joustra (Forbion)
Seaport Therapeutics
Series BOct 2024$230M
$330M
Co-investors: James Healy (Financial Services, Financial Technology, and Business Services), Robert Nelsen (ARCH Venture Partners)
Pharvaris
Post Ipo EquityJun 2023$70M
Series CNov 2020$80M
Series BSep 2019$66M
$220M
Co-investors: Richard Gaster (venBio Partners)
Javara Research
Series BApr 2022$40M
$40M
Centessa Pharmaceuticals
Series AFeb 2021$250M
$250M
Co-investors: Arjun Goyal (Vida Ventures, LLC)
Kinnate Biopharma
Series BDec 2019$75M
Series AApr 2018$22M
$200M
Co-investors: Michael Rome (Foresite Capital), Carl Gordon (OrbiMed Advisors), Peter Kolchinsky (RA Capital)
Managing Director and Global Head of Life Sciences General Atlantic2020 - Present
Associate Principal Mckinsey & CompanyPresent
Managing Director Foresite CapitalPresent
Partner Aisling CapitalPresent
Associate Principal McKinsey & CompanyPresent
Managing Director Foresite Capital Management2015 - 2020
Partner Aisling Capital LLC2004 - 2014
Osler Medical Housestaff Johns Hopkins Hospital1998 - 1999
Harvard Medical School MD Medicine
Yale University BA Molecular Biophysics and Biochemistry; English
Sign in with Google →
Sign in with Google →